Pluri Inc. Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss
Pluri Inc. (PLUR) reported Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss of -$850.00 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2019-09-12.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments · last filed 2019-09-12
- Pluri Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2018 was -$850.00K.
- Pluri Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2017 was -$767.00K.
- Pluri Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2016 was -$38.00K.
| Period end | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|
| 2018-06-30 | -$850.00K 10-K · filed 2019-09-12 |
| 2017-06-30 | -$767.00K 10-K · filed 2019-09-12 |
| 2016-06-30 | -$38.00K 10-K · filed 2018-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |